-
To drive down costs, insurers are delivering high-priced infusion drugs via third-party pharmacies. Hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."
-
At least eight states have implemented or are considering limits on what patients can be billed for the use of a hospital’s facilities even without having stepped foot in the building.
-
Designed to prevent doctors from deploying expensive, ineffectual procedures, preauthorization has morphed into a monster that denies or delays care, burdens physicians with paperwork and perpetuates racial disparities.
-
The billionaire entrepreneur, Dallas Mavericks owner and "Shark Tank" star is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.
-
White House officials said the decline in debt could reduce fears about medical bills that can prevent people from making needed doctor appointments and filling pharmaceutical prescriptions.
-
Medicare suddenly stopped paying for the pricey drug that prolongs his life. As he waits for an appeal, this retired physician wonders if he should give up treatment to spare his family the cost.
-
While some doctors seem eager for a huge payoff, others are warily watching what happens when private equity firms take charge of orthopedic practices.
-
What would a world without medical debt look like? In Germany's former coal-mining region medical debt is almost unknown, despite economic challenges and health problems. Here's why.
-
States, tribes, and local governments are figuring out how best to spend billions of dollars from an opioid lawsuit settlement. One option they’re considering is funding peer support specialists, who guide people recovering from addiction as they do it themselves.
-
Private equity firms have shelled out almost $1 trillion to acquire nearly 8,000 health care businesses across the country - including Florida - in deals almost always hidden from federal regulators.